Yahoo Web Search

  1. This change outpaced the S&P 500's 0.45% loss on the day. Heading into today, shares of the company had gained 1.16% over the past month, outpacing the Medical sector's loss of 1.24% and the ...

  2. Company claims Oklahoma judge miscalculated opioid award

    Associated Press via Yahoo FinanceOct 02 17:41 PM

    The company also is asking for a reduction in the judgment based on pre-trial settlements totaling $355 million that the state reached with Oxycontin-maker Purdue Pharma and Israeli-owned Teva ...

  3. AstraZeneca's Fasenra Gets FDA Nod for Self-Administration

    Zacks via Yahoo FinanceOct 07 12:23 PM

    AstraZeneca plc AZN announced that the FDA has approved a self-administration option for its asthma drug, Fasenra (benralizumab) in a new delivery method — a pre-filled, single-use auto-injector ...

  4. The Market Tells Opioid Drugmakers to Settle Up

    Bloomberg via Yahoo FinanceOct 02 16:41 PM

    Johnson & Johnson late Tuesday announced its first legal settlement over the pharmaceutical giant’s alleged role in spurring the opioid crisis, a modest $20 million deal with two Ohio ...

  5. Emergent BioSolutions Inc. EBS is a global specialty biopharmaceutical company that offer specialized products to health care providers and governments to fulfil unmet medical needs and combat ...

  6. Johnson & Johnson (NYSE: JNJ ) announced a $20.4-million agreement Wednesday with the Ohio counties of Cuyahoga and Summit to settle an opioid lawsuit with the state, removing the company from federal ...

  7. Bausch Files Lawsuit Against Novartis' Sandoz, Shares Down

    Zacks via Yahoo FinanceOct 03 20:47 PM

    The company along with its wholly-owned subsidiary, Salix Pharmaceuticals, and Salix's licensor Alfasigma announced that they have filed a lawsuit against Sandoz Inc., the generics division ...

  8. Lilly Gets FDA Approval for New Oral Tablets for Migraine

    Zacks via Yahoo FinanceOct 14 14:14 PM

    Eli Lilly & Company LLY announced that the FDA has approved lasmiditan for the treatment of acute migraine headaches, with or without aura, in adults. Lasmiditan, an oral 5-HT1F agonist, is ...

  9. Three drug distributors are in talks with state and local governments to settle thousands of opioid lawsuits for $18 billion, the Wall Street Journal reported on Tuesday, citing people familiar ...

  10. Those companies, along with Johnson & Johnson, have been negotiating a settlement they value at roughly $50 billion...

  1. Ads
    related to Teva Pharmaceutical Industries Ltd